Mabcure Stock Performance
| MBCI Stock | USD 0.0001 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and MabCure are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MabCure has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, MabCure is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 3415.00 | |
| Total Cashflows From Investing Activities | 53.2 K |
MabCure |
MabCure Relative Risk vs. Return Landscape
If you would invest 0.01 in MabCure on September 3, 2024 and sell it today you would earn a total of 0.00 from holding MabCure or generate 0.0% return on investment over 90 days. MabCure is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than MabCure, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MabCure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MabCure's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as MabCure, and traders can use it to determine the average amount a MabCure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MBCI |
Based on monthly moving average MabCure is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MabCure by adding MabCure to a well-diversified portfolio.
MabCure Fundamentals Growth
MabCure Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of MabCure, and MabCure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MabCure Pink Sheet performance.
| Return On Equity | -1.25 | |||
| Return On Asset | -0.0422 | |||
| Operating Margin | (1.42) % | |||
| Current Valuation | 643.64 K | |||
| Shares Outstanding | 64.36 M | |||
| Price To Earning | (0.02) X | |||
| Price To Book | 0.06 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 500 K | |||
| EBITDA | (12.05 M) | |||
| Cash And Equivalents | 146.44 K | |||
| Total Debt | 304.98 K | |||
| Debt To Equity | 0.08 % | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (61.39 K) | |||
| Earnings Per Share | (0.19) X | |||
| Total Asset | 4.81 M | |||
About MabCure Performance
By evaluating MabCure's fundamental ratios, stakeholders can gain valuable insights into MabCure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MabCure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MabCure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. MabCure Inc. was founded in 2006 and is based in White Plains, New York. Mabcure is traded on OTC Exchange in the United States.Things to note about MabCure performance evaluation
Checking the ongoing alerts about MabCure for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for MabCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MabCure generated a negative expected return over the last 90 days | |
| MabCure has some characteristics of a very speculative penny stock | |
| MabCure has a very high chance of going through financial distress in the upcoming years | |
| MabCure currently holds 304.98 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. MabCure has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist MabCure until it has trouble settling it off, either with new capital or with free cash flow. So, MabCure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MabCure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MabCure to invest in growth at high rates of return. When we think about MabCure's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 500 K. Net Loss for the year was (12.26 M) with profit before overhead, payroll, taxes, and interest of 500 K. | |
| MabCure currently holds about 146.44 K in cash with (61.39 K) of positive cash flow from operations. |
- Analyzing MabCure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MabCure's stock is overvalued or undervalued compared to its peers.
- Examining MabCure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MabCure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MabCure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MabCure's pink sheet. These opinions can provide insight into MabCure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MabCure Pink Sheet analysis
When running MabCure's price analysis, check to measure MabCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MabCure is operating at the current time. Most of MabCure's value examination focuses on studying past and present price action to predict the probability of MabCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MabCure's price. Additionally, you may evaluate how the addition of MabCure to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |